成人克罗恩病与溃疡性结肠炎患者的外科管理:巴西克罗恩病与结肠炎组织(GEDIIB)共识
该共识由代表巴西炎症性肠病研究组(GEDIIB)的结直肠外科医生和胃肠病学家制定,采用快速审查方法为推荐/声明提供支持,并按疾病表型、手术指征和围手术期管理进行结构化映射。推荐/声明经改良Delphi专家组投票,共三轮:两轮使用个性化匿名在线投票平台,一轮面对面会议;每轮同意率≥80%即视为达成共识。共识重点涉及择期和急诊手术,确定何时指示手术以及哪些术式可能更合适,面向治疗和管理成人CD或UC的胃肠病学家和外科医生。文中还给出了生物制剂时代诊断后10年手术风险:UC为9.2%,CD为26.2%。
要点
- 生物制剂时代,IBD诊断后10年手术风险UC为9.2%、CD为26.2%。
- 共识按疾病表型、手术指征和围手术期管理结构化映射外科推荐。
- 推荐/声明采用快速审查方法支持,并经改良Delphi法三轮投票(两轮在线、一轮面对面)。
- 每轮推荐/声明同意率≥80%即视为达成共识。
- 共识重点涉及择期和急诊手术,确定何时指示手术及哪些术式可能更合适。
适用人群与场景
- 成人克罗恩病或溃疡性结肠炎患者,面向治疗和管理这类患者的胃肠病学家和外科医生。
研究设计与关键结果
- 制定机构:巴西炎症性肠病研究组(GEDIIB),由结直肠外科医生和胃肠病学家组成。
- 方法:采用快速审查方法为推荐/声明提供支持;推荐按疾病表型、手术指征和围手术期管理结构化映射。
- 投票:改良Delphi专家组投票共三轮,两轮使用个性化匿名在线投票平台,一轮面对面会议;每轮同意率≥80%即视为达成共识。
- 共识重点涉及择期和急诊手术,确定何时指示手术以及哪些术式可能更合适。
证据类型、等级与局限
- 证据类型:指南/共识;推荐/声明由快速审查方法支持,经改良Delphi法三轮投票达成共识(每轮同意率≥80%)。
- 局限:原文未报告局限性
指南或共识出处
- 指南名称:成人克罗恩病与溃疡性结肠炎患者的外科管理:巴西克罗恩病与结肠炎组织(GEDIIB)共识;发布机构:巴西炎症性肠病研究组(GEDIIB);期刊:Arq Gastroenterol。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Despite optimized medical therapy, contemporary risk of surgery in inflammatory bowel diseases (IBD) after 10 years of diagnosis is 9.2% in patients with ulcerative colitis (UC) and 26.2% in Crohn's disease, (CD) in the biological era.
OBJECTIVE: This consensus aims to detail guidance to the most appropriate surgical procedures in different IBD scenarios. In addition, it details surgical indications and perioperative management of adult patients with CD and UC.
METHODS: Our consensus was developed by colorectal surgeons and gastroenterologists representing the Brazilian Study Group of Inflammatory Bowel Diseases (GEDIIB), with the Rapid Review methodology being conducted to support the recommendations/statements. Surgical recommendations were structured and mapped according to the disease phenotypes, surgical indications, and techniques. After structuring the recommendations/statements, the modified Delphi Panel methodology was used to conduct the voting by experts in IBD surgery and gastroenterology. This consisted of three rounds: two using a personalized and anonymous online voting platform and one face-to-face presential meeting. Whenever participants did not agree with specific statements or recommendations, an option to outline possible reasons was offered to enable free-text responses and provide the opportunity for the experts to elaborate or explain disagreement. The consensus of recommendations/statements in each round was considered to have been reached if there was ≥80% agreement.
RESULTS AND CONCLUSION: This consensus addressed the most relevant information to guide the decision-making process for adequate surgical management of CD and UC. It synthesizes recommendations developed from evidence-based statements and state-of-art knowledge. Surgical recommendations were structured and mapped according to the different disease phenotypes, indications for surgery and perioperative management. Specific focus of our consensus was given to elective and emergency surgical procedures, determining when to indicate surgery and which procedures may be the more appropriate. The consensus is targeted to gastroenterologists and surgeons interested in the treatment and management of adult patients with CD or UC and supports decision-making of healthcare payors, institutional leaders, and/or administrators.
参考来源
- Zabot GP, Cassol OS, Quaresma AB, et al. SURGICAL MANAGEMENT OF ADULT CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN'S DISEASE AND COLITIS (GEDIIB). Arq Gastroenterol. 2023. PMID: 36995887. doi:10.1590/S0004-2803.2022005S1-01
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。